SCHEMBL2467501

SCHEMBL2467501

C=CCCCC(O)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18052645 1.00
SCHEMBL6905587 1.00
SCHEMBL29204812 0.94 USP2 (0.46)
SCHEMBL3115802 0.93 USP2 (0.49)
SCHEMBL3123238 0.91 USP2 (0.51)
SCHEMBL8483019 0.91 USP2 (0.51)
SCHEMBL17494179 0.91 USP2 (0.51)
SCHEMBL3116470 0.91 USP2 (0.51)
SCHEMBL3111942 0.91 USP2 (0.51)
3-Octanol SCHEMBL28698995 0.86 TSHR (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-59078140-A None JP disclosed
US-20240092731-A1 CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF ULTRAGENYX PHARMACEUTICAL INC. 2024-03-21 US disclosed
US-11753369-B2 Creatine prodrugs, compositions and methods of use thereof ULTRAGENYX PHARMACEUTICAL INC. (US) 2023-09-12 US disclosed
US-11753369-B2 Creatine prodrugs, compositions and methods of use thereof ULTRAGENYX PHARMACEUTICAL INC. (US) 2023-09-12 US disclosed
CN-111417620-B Creatine prodrugs, compositions thereof, and methods of use 奥特吉尼克斯制药公司 2023-08-25 CN disclosed
CN-109982989-B Process for producing dienes 维尔萨利斯股份公司 2023-05-12 CN disclosed
US-11498887-B2 Process for producing dienes VERSALIS S.P.A. (IT) 2022-11-15 US disclosed
US-20220339610-A1 CATALYST COMPRISING COKE AND PROCESS FOR THE PRODUCTION OF DIENES ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2022-10-27 US disclosed
US-20220227703-A1 CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF ULTRAGENYX PHARMACEUTICAL INC. 2022-07-21 US disclosed
EP-4021637-A1 CATALYST COMPRISING COKE AND PROCESS FOR THE PRODUCTION OF DIENES Versalis S.p.A. (IT) 2022-07-06 EP disclosed
EP-1734061-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS, INC. (JP) 2006-12-20 EP disclosed
EP-1642931-A1 EMULSION COMPOSITION OF MODIFIED POLYPROPYLENE Tonen Chemical Corporation (JP) 2006-04-05 EP disclosed
US-20040122192-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. 2004-06-24 US disclosed
EP-1131270-B1 PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE 3M INNOVATIVE PROPERTIES CO (US) 2004-04-07 EP disclosed
US-20020156207-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2002-10-24 US disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed
EP-1131270-A1 PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE 3M Innovative Properties Company (US) 2001-09-12 EP disclosed
US-6248889-B1 FORMING MIXTURE COMPRISING AT LEAST ONE FLUORINATED, SATURATED ALIPHATIC OR ALICYCLIC SULFONYL FLUORIDE AND AT LEAST ONE PRIMARY OR SECONDARY ALCOHOL, ADDING MOLAR EXCESS OF STRONG, APROTIC, NON-NUCLEOPHILIC HINERED ORGANIC BASE 3M INNOVATIVE PROPERTIES COMPANY 2001-06-19 US disclosed
WO-2000031003-A1 PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-06-02 WO disclosed
JP-S5978140-A PREPARATION OF 7-OCTEN-3-ONE KURARAY CO LTD 1984-05-04 JP disclosed